Literature DB >> 25274988

Absence of Shb impairs insulin secretion by elevated FAK activity in pancreatic islets.

Ida Alenkvist1, Oleg Dyachok1, Geng Tian1, Jia Li1, Saba Mehrabanfar1, Yang Jin1, Bryndis Birnir1, Anders Tengholm2, Michael Welsh2.   

Abstract

The Src homology-2 domain containing protein B (SHB) has previously been shown to function as a pleiotropic adapter protein, conveying signals from receptor tyrosine kinases to intracellular signaling intermediates. The overexpression of Shb in β-cells promotes β-cell proliferation by increased insulin receptor substrate (IRS) and focal adhesion kinase (FAK) activity, whereas Shb deficiency causes moderate glucose intolerance and impaired first-peak insulin secretion. Using an array of techniques, including live-cell imaging, patch-clamping, immunoblotting, and semi-quantitative PCR, we presently investigated the causes of the abnormal insulin secretory characteristics in Shb-knockout mice. Shb-knockout islets displayed an abnormal signaling signature with increased activities of FAK, IRS, and AKT. β-catenin protein expression was elevated and it showed increased nuclear localization. However, there were no major alterations in the gene expression of various proteins involved in the β-cell secretory machinery. Nor was Shb deficiency associated with changes in glucose-induced ATP generation or cytoplasmic Ca(2+) handling. In contrast, the glucose-induced rise in cAMP, known to be important for the insulin secretory response, was delayed in the Shb-knockout compared with WT control. Inhibition of FAK increased the submembrane cAMP concentration, implicating FAK activity in the regulation of insulin exocytosis. In conclusion, Shb deficiency causes a chronic increase in β-cell FAK activity that perturbs the normal insulin secretory characteristics of β-cells, suggesting multi-faceted effects of FAK on insulin secretion depending on the mechanism of FAK activation.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  FAK; Src homology 2; cAMP; insulin secretion

Mesh:

Substances:

Year:  2014        PMID: 25274988     DOI: 10.1530/JOE-14-0531

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  2 in total

1.  Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas.

Authors:  Xiujuan Li; Kailash Singh; Zhengkang Luo; Mariela Mejia-Cordova; Maria Jamalpour; Björn Lindahl; Ganlin Zhang; Stellan Sandler; Michael Welsh
Journal:  Oncotarget       Date:  2018-04-10

2.  Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB.

Authors:  Ilkka Pietilä; Djenolan Van Mourik; Andreas Tamelander; Vitezslav Kriz; Lena Claesson-Welsh; Anders Tengholm; Michael Welsh
Journal:  Cells       Date:  2019-12-15       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.